Great day for ANP looks like the market is waking up to what a gem it is.... like others here have said i'm not getting any work done today lol.
Credits for R&D of 360K already received with more coming check the last presentation/announcement… also they have said no CR for 2011. They had 1.4 million at the start of Oct and the options are in the money as this continues to climb people will exercise IMO.
ODA means 12 weeks for P2a/b…. P3 is 18 months DYOR!! they will partner beforehand given the nature of this drug being early reduction in IGF, the risk in proceeding forward is significantly reduced which is why they can partner with some certainty early on.
Mipomersen is approved in Europe and will be on market by March. In the USA it will be on market by October 2012 due to FDA delays… but either way the hurdles have already been jumped here and validation of gen2 antisense is sealed.
Guys please DYOR, the one pip traders on here who are bullish one minute and start scaremongering the next are obvious…
JMO, Good luck and please DYOR!
- Forums
- ASX - By Stock
- PER
- witnessing the start of a 5 to Disallowed.
witnessing the start of a 5 to Disallowed., page-198
-
- There are more pages in this discussion • 76 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.0¢ |
Change
-0.001(1.23%) |
Mkt cap ! $72.12M |
Open | High | Low | Value | Volume |
8.2¢ | 8.2¢ | 8.0¢ | $63.52K | 777.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 43377 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.2¢ | 97561 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 43377 | 0.080 |
2 | 212658 | 0.078 |
1 | 200000 | 0.077 |
3 | 91500 | 0.076 |
4 | 206988 | 0.075 |
Price($) | Vol. | No. |
---|---|---|
0.082 | 97561 | 1 |
0.083 | 214000 | 1 |
0.084 | 67142 | 2 |
0.085 | 141000 | 2 |
0.086 | 106100 | 2 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
PER (ASX) Chart |